Advaxis to Present Updated Clinical and Immunogenicity Data
Overall response rate of 14% and disease control rate of 36% in Part B of ADXS-503 trial with durable clinical benefit as an add-on therapy to patients...
Stay updated with breaking news from Advaxis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Overall response rate of 14% and disease control rate of 36% in Part B of ADXS-503 trial with durable clinical benefit as an add-on therapy to patients...
Analysts’ new coverage for Tuesday, May 24th: StockNews.com assumed coverage on shares of Altisource Asset Management (NYSE:AAMC). They issued a hold rating on the stock. StockNews.com started coverage on shares of Almaden Minerals (NYSE:AAU). StockNews.com issued a sell rating on the stock. StockNews.com initiated coverage on shares of Acme United (NYSE:ACU). The firm issued a […]
Research Analysts’ new coverage for Tuesday, May 17th: StockNews.com started coverage on shares of Acme United (NYSE:ACU). The firm issued a hold rating on the stock. StockNews.com assumed coverage on shares of Advaxis (NASDAQ:ADXS). The firm issued a sell rating on the stock. StockNews.com started coverage on shares of Allied Healthcare Products (NASDAQ:AHPI). The firm […]
Research Analysts’ new coverage for Tuesday, May 10th: StockNews.com began coverage on shares of Acme United (NYSE:ACU). They issued a hold rating on the stock. StockNews.com assumed coverage on shares of Mega Matrix (NYSE:ACY). They issued a hold rating on the stock. JMP Securities assumed coverage on shares of Agree Realty (NYSE:ADC). They issued an […]
Equities Research Analysts’ new coverage for Monday, May 9th: StockNews.com began coverage on shares of Advaxis (NASDAQ:ADXS). The firm issued a sell rating on the stock. StockNews.com started coverage on shares of Advaxis (NASDAQ:ADXS). They issued a sell rating on the stock. StockNews.com assumed coverage on shares of Allied Healthcare Products (NASDAQ:AHPI). StockNews.com issued a […]